State Ledger
Company profile

Lantern Pharma Inc. CIK 1763950

Ticker
LTRN (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Dallas, TX 75201
Fiscal year end
2025 (FY)
Market Data
Close
$0.71
Change
-$0.03
Change %
-4.44%
Volume
911

LTRN · trading date Oct 13, 2026 · previous close $0.74 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$17.12M
Total assets
$11.04M
Total liabilities
$4.50M
Stockholders' equity
$6.53M
Cash & equivalents
$4.42M
Operating income
-$17.98M
Operating cash flow
-$15.68M
Capital expenditures
$1.7K

Fiscal year 2025, via 10-K filed 2026-03-30. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$15.68M
Free cash flow margin
—
Liabilities / assets
40.8%
Equity / assets
59.2%
CapEx / revenue
—
Operating cash flow / net income
0.92×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$17.12M $11.04M $4.50M $6.53M
2024 — -$20.78M $25.57M $4.38M $21.19M
2023 — -$15.96M $43.65M $2.74M $40.91M
2022 — -$14.26M $58.84M $2.80M $56.04M
2021 — -$12.36M $73.95M $2.38M $71.57M
Company Details
SIC code
2834
State of incorporation
TX
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-08-14
Financials filed via
Form 10-K
filed 2026-03-30

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Dallas, TX 75201
1920 MCKINNEY AVENUE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:58 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Texas — Public Companies